Xiemin Cao Selected Research

Xiemin Cao Research Topics

6	Body Weight (Weight, Body) 11/2022 - 04/2008
4	Inflammation (Inflammations) 11/2022 - 01/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2017
3	Obesity 10/2019 - 11/2017
2	Atherosclerosis 11/2022 - 01/2013
2	Weight Loss (Weight Reduction) 11/2019 - 04/2008
2	Myocardial Infarction 01/2018 - 08/2014
1	Weight Gain 11/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Heart Diseases (Heart Disease) 11/2017
1	Insulin Resistance 01/2017
1	Colonic Polyps 03/2015
1	Cardiomyopathies (Cardiomyopathy) 08/2014

8	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 04/2008
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 04/2008
3	LipidsIBA 11/2022 - 01/2013
3	gastric inhibitory polypeptide receptorIBA 11/2022 - 01/2018
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 04/2008
3	Insulin (Novolin)FDA Link 01/2021 - 04/2008
2	IncretinsIBA 11/2022 - 01/2019
2	Apolipoproteins E (ApoE)IBA 11/2022 - 01/2013
2	Messenger RNA (mRNA)IBA 11/2022 - 10/2019
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2013
1	T Cell Transcription Factor 1IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	EnzymesIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 10/2019
1	Glucagon (Glukagon)FDA Link 01/2019
1	CytokinesIBA 01/2019
1	Sterol Esterase (Hormone-Sensitive Lipase)IBA 01/2018
1	AdipokinesIBA 01/2017
1	Exenatide (Byetta)FDA Link 03/2015
1	Fibroblast Growth Factor 7 FDA Link 03/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2014
1	Streptozocin (Streptozotocin)FDA Link 01/2013
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2013
1	Drinking WaterIBA 01/2013
1	taspoglutideIBA 01/2013

2	Therapeutics 01/2020 - 01/2017